Uchikawa; Osamu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Uchikawa; Osamu.The latest application filed is for "pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues".

Company Profile

0.13.15

Uchikawa; Osamu - Hyogo JP
Uchikawa; Osamu - Kanagawa JP
Uchikawa; Osamu - Osaka N/A JP
UCHIKAWA; Osamu - Osaka-shi JP
Uchikawa; Osamu - Kobe JP
Uchikawa, Osamu - Kobe-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions And Methods For Treating Age-related Macular Degeneration With Melatonin Analogues App 20160000746 - Baron; David ; et al.	2016-01-07
Pharmaceutical Compositions and Methods for Treating Age-Related Macular Degeneration with Melatonin Analogues App 20150142085 - Baron; David ; et al.	2015-05-21
Tricyclic compound and pharmaceutical use thereof Grant 8,895,591 - Uchikawa , et al. November 25, 2	2014-11-25
Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues Grant 8,785,491 - Baron , et al. July 22, 2	2014-07-22
Tricyclic Compound And Pharmaceutical Use Thereof App 20140011849 - UCHIKAWA; Osamu ; et al.	2014-01-09
Tricyclic compound and pharmaceutical use thereof Grant 8,552,037 - Uchikawa , et al. October 8, 2	2013-10-08
Tricyclic Compound And Pharmaceutical Use Thereof App 20130079374 - UCHIKAWA; Osamu ; et al.	2013-03-28
Tricyclic compound and pharmaceutical use thereof Grant 8,349,879 - Uchikawa , et al. January 8, 2	2013-01-08
Tricyclic compound and medical use thereof Grant 8,273,761 - Uchikawa , et al. September 25, 2	2012-09-25
Tricyclic compound and pharmaceutical use thereof Grant 8,247,429 - Uchikawa , et al. August 21, 2	2012-08-21
Tricyclic compound and pharmaceutical use thereof Grant 8,236,837 - Uchikawa , et al. August 7, 2	2012-08-07
Tricyclic compound and pharmaceutical use thereof Grant 8,030,337 - Uchikawa , et al. October 4, 2	2011-10-04
Pharmaceutical Compositions And Methods For Treating Age-related Macular Degeneration With Melatonin Analogues App 20110229464 - Baron; David ; et al.	2011-09-22
Tricyclic Compound And Pharmaceutical Use Thereof App 20110196003 - Uchikawa; Osamu ; et al.	2011-08-11
Tricyclic Compound And Pharmaceutical Use Thereof App 20110190361 - UCHIKAWA; Osamu ; et al.	2011-08-04
Fused Heterocyclic Compound App 20100029619 - Uchikawa; Osamu ; et al.	2010-02-04
Tricyclic Compound And Medical Use Thereof App 20100029707 - Uchikawa; Osamu ; et al.	2010-02-04
Tricyclic Compound And Pharmaceutical Use Thereof App 20100010038 - Uchikawa; Osamu ; et al.	2010-01-14
Tricyclic Compound And Pharmaceutical Use Thereof App 20090182023 - Uchikawa; Osamu ; et al.	2009-07-16
Condensed Imidazole Compound And Use Thereof App 20080167314 - Uchikawa; Osamu ; et al.	2008-07-10
Condensed pyrazole derivatives, process for producing the same and use thereof Grant 6,949,648 - Uchikawa , et al. September 27, 2	2005-09-27
Furoisoquinoline derivatives, process for producing the same and use thereof Grant 6,924,292 - Kawano , et al. August 2, 2	2005-08-02
Hsp inductor App 20040097539 - Terashita, Zen- ichi ; et al.	2004-05-20
Furoisoquinoline derivatives, process for producing the same and use thereof App 20040092582 - Kawano, Yasuhiko ; et al.	2004-05-13
Condensed pyrazole derivatives, process for producing the same and use thereof App 20030187014 - Uchikawa, Osamu ; et al.	2003-10-02
Benzocycloalkene compounds, their production and use Grant 6,235,789 - Ohkawa , et al. May 22, 2	2001-05-22
Tricyclic compounds, their production and use Grant 6,034,239 - Ohkawa , et al. March 7, 2	2000-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.